Bragg Financial Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Buy
17,573
+12,780
+267% +$1.58M 0.07% 183
2025
Q4
$603K Buy
4,793
+1,520
+46% +$198K 0.02% 252
2025
Q3
$479K Sell
3,273
-141
-4% -$21.3K 0.02% 271
2025
Q2
$532K Buy
3,414
+1,006
+42% +$160K 0.02% 257
2025
Q1
$396K Buy
2,408
+55
+2% +$9.15K 0.02% 273
2024
Q4
$383K Buy
2,353
+471
+25% +$84.2K 0.02% 276
2024
Q3
$368K Buy
1,882
+14
+0.7% +$2.58K 0.02% 271
2024
Q2
$324K Sell
1,868
-194
-9% -$32.3K 0.01% 272
2024
Q1
$349K Buy
2,062
+162
+9% +$30.3K 0.02% 269
2023
Q4
$375K Sell
1,900
-23
-1% -$4.07K 0.02% 260
2023
Q3
$335K Buy
1,923
+32
+2% +$5.81K 0.02% 268
2023
Q2
$326K Hold
1,891
0.02% 276
2023
Q1
$315K Sell
1,891
-1
-0.1% -$164 0.02% 274
2022
Q4
$277K Buy
+1,892
New +$280K 0.02% 279

Other funds holding ZTS

Bragg Financial Advisors's ZTS Position: Q1 2026 in Review

Bragg Financial Advisors increased its Zoetis (ZTS) stake by 267% in Q1 2026, buying an estimated $1.58M and bringing the position to 17,573 shares worth $2.08M. The position accounts for 0.07% of the portfolio, ranked #183.

Bragg Financial Advisors first reported a position in ZTS in Q4 2022 and has held it in 14 quarters since. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Bragg Financial Advisors held 17,573 shares of Zoetis worth $2.08M as of Q1 2026.
  • Bragg Financial Advisors bought 12,780 Zoetis shares in Q1 2026, an estimated $1.58M.
  • Zoetis made up 0.07% of Bragg Financial Advisors's portfolio in Q1 2026, its #183 holding.
  • Bragg Financial Advisors first reported a position in Zoetis in Q4 2022 and has held it in 14 quarters since.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Bragg Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.